373OResults of phase II trial of SL-701, a novel...

Annals of Oncology 2018 / 10 Vol. 29; Iss. suppl_8

373OResults of phase II trial of SL-701, a novel immunotherapy targeting IL-13Ra2, EphA2, and survivin, in adults with second-line recurrent glioblastoma (GBM)

Peereboom, D, Nabors, L B, Kumthekar, P, Badruddoja, M, Fink, K, Lieberman, F, Phuphanich, S, Dunbar, E, Walbert, T, Schiff, D, Tran, D D, Ashby, L S, Butowski, N, Iwamoto, F, Lindsay, R, Bullington,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
29
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy273.361
Date:
October, 2018
File:
PDF, 109 KB
english, 2018
Conversion to is in progress
Conversion to is failed